Inglis F

References (4)

Title : Safety and tolerability of once-daily versus twice-daily memantine: a randomised, double-blind study in moderate to severe Alzheimer's disease - Jones_2007_Int.J.Geriatr.Psychiatry_22_258
Author(s) : Jones RW , Bayer A , Inglis F , Barker A , Phul R
Ref : Int J Geriatr Psychiatry , 22 :258 , 2007
Abstract :
PubMedSearch : Jones_2007_Int.J.Geriatr.Psychiatry_22_258
PubMedID: 17243195

Title : Effect of ispronicline, a neuronal nicotinic acetylcholine receptor partial agonist, in subjects with age associated memory impairment (AAMI) - Dunbar_2007_J.Psychopharmacol_21_171
Author(s) : Dunbar GC , Inglis F , Kuchibhatla R , Sharma T , Tomlinson M , Wamsley J
Ref : J Psychopharmacol , 21 :171 , 2007
Abstract :
PubMedSearch : Dunbar_2007_J.Psychopharmacol_21_171
PubMedID: 17329297

Title : Rivastigmine and QT interval prolongation -
Author(s) : Inglis F
Ref : British Journal of Psychiatry , 182 :549 , 2003
PubMedID: 12777350

Title : The tolerability and safety of cholinesterase inhibitors in the treatment of dementia - Inglis_2002_Int.J.Clin.Pract.Suppl_127_45
Author(s) : Inglis F
Ref : Int J Clin Pract Suppl , 127 :45 , 2002
Abstract :
PubMedSearch : Inglis_2002_Int.J.Clin.Pract.Suppl_127_45
PubMedID: 12139367